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Abstract
We report an unusual case of a 70-year-old male with history of hereditary spherocytosis (HS) and secondary
paraspinal extramedullary hematopoiesis with a concurrent follicular lymphoma. The lesion presented as a thoracic
paraspinal mass of 9 cm, extending longitudinally between T6 and T9 vertebral bodies. Incisional biopsy revealed
that this mass included mature hematopoietic tissue compatible with extramedullary hematopoiesis (EMH).
The tissue also presented an extensive and diffuse infiltration by an atypical lymphoid population composed
predominantly by small cells. The immunohistochemical study revealed that the atypical lymphoid population
had a germinal center phenotype, consistent with the diffuse variant of follicular lymphoma (FL). The simultaneous
presence of both EMH and FL in the same lesion made the interpretation and the final diagnosis of this case difficult.
The presence of EMH in this clinical context may eclipse the diagnosis of the underlying lymphoproliferative
neoplasm. The close association between the tumor cells and extramedullary hematopoietic tissue in the
absence of lymphadenopathies or other tissue involvement suggests a relationship of this tumor with the recently
described primary FL of the bone marrow.
Background
Extramedullary hematopoiesis (EMH) defined by the
presence of hematopoietic tissue outside the bone mar-
row, is a physiological phenomenon in the liver during
the normal fetal development, but it is not normal after
birth and must be considered a pathological finding [1].
EMH frequently affects the spleen and liver, usually
forming small aggregates diffusely located in the paren-
chyma, but it can also appear as a pseudotumoral mass,
especially in atypical locations. This lesion can be symp-
tomatic, presenting systemic and/or local symptoms by
compression of adjacent structures [1, 2]. Pathologic
EMH is usually associated with other hematologic disor-
ders affecting the bone marrow or peripheral blood. The
most frequent underlying diseases associated with EMH
are some chronic myeloproliferative neoplasms, chronic
lymphoproliferative disorders, chronic hemolytic and
inherited anemias, such as thalassemia, sickle cell dis-
ease or hereditary spherocytosis (HS) [3, 4].
Hereditary spherocytosis is an inherited form of
chronic hemolytic anemia secondary to deficit of some
of the cytoskeletal proteins associated with the erythro-
cyte membrane (Band 3, Ankyrin 1, 4.2 protein, alpha or
beta Spectrin). The usual findings in this disease are the
presence of spherocytes in peripheral blood, signs of
chronic hemolytic anemia and splenomegaly. Eventually
it could be associated with EMH in typical or atypical
sites [3, 4].
The association between EMH and a concurrent
lymphoproliferative disorder is uncommon. The pseu-
dotumoral presentation of EMH and the difficulty to
recognize the underlying lymphoid neoplasm hinders
the diagnosis, therefore delaying the correct management
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of these patients. Here we present a patient with tumoral
EMH associated with a follicular lymphoma and a review
the literature of this uncommon association.
Case report
A 70 y-o male was admitted to the hospital because of a
large paravertebral tumoral mass. The patient had his-
tory of HS with mild clinical signs of hemolysis, such as
pallor, jaundice and splenomegaly. Laboratory tests were
consistent with underlying chronic hemolysis, with
hemoglobin levels around 10–11 g/dl, reticulocyte count
of approximately 5 %, ferritin levels between 376 and
470 ng/ml and transferrin saturation around 40 to 60 %.
Routine abdominal ultrasonography showed splenomeg-
aly and biliary sludge in gallbladder. The patient was in
treatment with folic acid. Due to an episode of a lower
respiratory infection, a CT scan and MRI were per-
formed, evidencing a thoracic paraspinal tumoral mass
of 9 × 4 × 2 cm, that extended along T6 to T9 vertebral
bodies and an inter-aorta-caval mass of 2.5 × 1.6 cm
with similar characteristics. A PET-CT showed a patho-
logical uptake in both paravertebral tumors, but also re-
vealed several lesions in right humerus, right femur and
L3 vertebral body (Fig 1a). With these findings, an inci-
sional biopsy of the main paravertebral mass, a bone
marrow trephine biopsy and a study of peripheral blood
were performed.
Pathological findings
Representative sections were routinely processed in buff-
ered formalin and embedded in paraffin, according to
standard procedures. Biopsy of the main paraspinal mass
revealed the presence of fragments of fibroconnective
and adipose tissue. In this tissue, we identified aggre-
gates of mature hematopoietic tissue composed of mega-
karyocytes without atypical features, a high proportion
of erythroid elements forming erythroid islands and a
small number of myeloid cells, with predominance of
mature forms. Dysplastic changes of megakaryocytes, ag-
gregates of megakaryocytes, left shifted maturation or an
increase in number of blast cells were absent. These find-
ings were consistent with extramedullary hematopoiesis.
In other areas of the same sample, the tissue was diffusely
infiltrated by an atypical lymphoid population of mainly
small cells with irregular, indented, hypercromatic nuclei
and a few large centroblast-like cells. Scattered mitotic fig-
ures were seen.
The immunohistochemical stains (carried out with an
automated immunostainer, Dako Autostainer, Glostrup,
Denmark) showed that the atypical cells had a B-cell
phenotype with positivity for CD20 and CD79a and
expressed the germinal center markers CD10, BCL6 and
LMO2, with coexpression of BCL2. There was a variable
expression of follicular dendritic cell markers (CD21 and
CD23). The atypical cells were negative for CD5, CD30
Fig. 1 PET scan imaging before and after four weeks of Rituximab. a PET/CT scan before immunotherapy. Note a large metabolically active
paravertebral mass of soft tissues adjacent to thoracic vertebral bodies T6 to T9 (arrow). A lesion in inter-aorto-caval mass is not visible at this
level. b PET scan after immunotherapy; partial uptake reduction of the main thoracic paravertebral mass (arrow) and the inter-aorto-caval
lesion (arrowhead)
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and CD138. The proliferation index assessed by the nu-
clear positivity for Ki-67 was low, about 20 %. A promin-
ent component of mature T-cells was found intermingled
with the atypical B-cells. These findings were consistent
with a diffuse infiltration by a follicular lymphoma (FL)
(Fig. 2a–g). FISH for IGH/BCL2 (Abbott Molecular,
Illinois) rearrangement was carried out using dual color-
dual fusion probes, and evidenced t(14;18) translocation
in 15–20 % of cells (Fig. 2h). The bone marrow biopsy
showed an erythroid hyperplasia and a small paratrabecu-
lar infiltration by CD20 positive cells. Additional markers
were not contributory. Histologic changes suggestive of a
chronic myeloproliferative neoplasm were absent.
The study of peripheral blood showed some small
spherical erythrocytes with dense cytoplasm consistent
with spherocytes. In addition, atypical centrocytic
Fig. 2 The biopsy of the paravertebral mass showed aggregates of mature hematopoietic tissue, with erythroid islands and normal
megakaryocytes consistent with EMH, (a) H&E 40x, (b) H&E 200x. In other areas the tissue was diffusely infiltrated by an atypical lymphoid
population of small cells with few large centroblast-like cells, (c) H&E 100x, (d) H&E 400x. The cells are positive for (e) CD20, (f) BCL6 and
(g) BCL2. h FISH shows an IGH@/BCL2 translocation in some cells (yellow arrows), (dual color dual fusion probe, x400)
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lymphoid cells with indented nuclei and mature chroma-
tin were also observed. Flow cytometry analysis identi-
fied a clonal population of B-cells (80 % of the total of
B-cells) with expression of lambda light chain, positive
for CD19, CD20, CD22, CD79b, CD23, FMC7 and nega-
tive for CD5, CD10, CD38, and CD43.
The patient began monotherapy treatment with Rituxi-
mab (375 mg/m2) during four weeks. Six months after
diagnosis, PET-CT showed reduction of the main para-
vertebral mass, the inter-aorta-caval mass and the lesion
in the humerus. A complete disappearance of the lesions
in the femur and vertebrae (Fig. 1b) was observed. Ritux-
imab was restarted and a splenectomy was performed
due to chronic hemolysis. The spleen did not show any
evidence of lymphoma. Six months after splenectomy,
the patient is in good clinical standing.
Discussion
HS is a group of chronic inherited anemias in which the
characteristic feature is the presence of spherocytes, de-
fined as small round erythrocytes with a higher concen-
tration of hemoglobin. The cause is a deficiency of
proteins associated with the erythroid membrane that
play a critical role in the capacity of cell deformability.
The proteins related to this disease are alpha-spectrin,
beta-spectrin, ankyrin 1, protein 4.2 and band 3. This
deficiency results in the instability of the cellular mem-
brane with subsequent formation of membrane vesicles
and secondary reduction of the surface-to-volume ratio.
The spherocytes are retained in the red pulp of the
spleen and part of these cells are destroyed, while the
rest survive and return to the peripheral blood with even
more spherocytic features. The majority of patients
present signs of hemolytic anemia, such as jaundice,
pallor and variable splenomegaly. Laboratory tests
show mild anemia, presence of spherocytes and retic-
ulocytes, higher mean corpuscular hemoglobin con-
centration and increase of the osmotic fragility of the
erythrocytes. The most frequent complication of this
form of chronic hemolytic anemia is the development
of bilirubin gallstones. Less frequently the patient
could present with skin lesions, myopathy, cardiovas-
cular disease, neuromuscular and SNC diseases [1, 2].
HS has been rarely described in association with neo-
plasms, including one diffuse large B cell lymphoma
[5], two acute lymphoblastic leukemias [6, 7], one
splenic B-cell lymphoma [8], one schwannoma [9] and
one ganglioneuroma [10]. The case of HS and ganglio-
neuroma presented initially as a mass in the adrenal
gland and a differential diagnosis with EMH was
considered.
EMH is defined by the presence of hematopoietic tis-
sue outside the bone marrow. This phenomenon could
be normal or pathologic. Pathologic EMH is usually as-
sociated with hematologic disorders affecting the bone
marrow, peripheral blood and less frequently with vascu-
lar diseases or can even appear without any other under-
lying disorder. Spleen and liver are typical sites for EMH
[3, 4]. In the largest case series, Koch et al. found 510 bi-
opsies reporting EMH. In 483 patients, this lesion oc-
curred in liver and spleen. In the rest of the patients, it
appeared in other sites, such as paraspinal region, lymph
nodes, retroperitoneum, lung, pleura, genitourinary re-
gion and skin. The underlying associated diseases were
chronic myeloproliferative neoplasms, such as primary
myelofibrosis, post polycythaemic myelofibrosis or chronic
myeloid leukemia, chronic lymphocytic leukemia, vascular
malformations and inherited or chronic hemolytic
anemias [3].
Development of extramedullary hematopoiesis in the
clinical context of HS has been well documented. Para-
spinal, thoracic and mediastinal regions are the most fre-
quent sites of involvement [11–20]. Independent of the
underlying disease, in some patients it may present as a
pseudotumoral mass, mimicking a solid tumor, and
therefore a differential diagnosis with other neoplasms
must be taken into account [21–23]. A concurrent lym-
phoproliferative disorder and EMH in the same lesion
has been described in only four case reports [24–27]. In
one case [24] there was no history of a previous lymphoid
Table 1 Clinical and pathologic features of EMH with concurrent lymphoproliferative neoplasm in the literature
Reference Gender Age (years) Anatomic site of EMH Previous history
of lymphoma
Concurrent lymphoid disease Last follow-up
Musolino A. et al., 2007 F 36 Central nervous system Yes AIDS-related central nervous
system lymphoma
Dead, 20 days after starting
treatment
Mudhar HS. et al., [24] F 81 Eye (uvea) No Intravascular diffuse large
B-cell lymphoma
Alive, short follow-up
Gupta N. et al., [26] NS NS Lymph node Yes T-cell leukemia Alive, 4 months of follow-up
Forest F. et al., [25] NS 53 Skin (surgical scar) Yes Marginal zone B-cell lymphoma Alive, 10 years of follow-up
Current Case M 70 Paraspinal mass
(D6 – D9)
No Follicular lymphoma, diffuse
variant
Alive, 6 months of follow-up
F: female; M: male; NS: Not specified
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neoplasm, and the development of the EMH probably was
in the context of a hemorragic infarct secondary to a
intravascular diffuse large B-cell lymphoma in the blood
vessels of the uvea. In the other three cases the lympho-
proliferative disorder was previously known and the find-
ing of EMH and a concurrent lymphoma was made
afterwords. The findings of these reports are summarized
in Table 1. This infrequent association between EMH and
lymphoma may underestimate the presence of an under-
lying atypical lymphoid infiltrate, especially when extra-
medullary hematopoiesis presents as a pseudotumoral
lesion in patients with chronic anemia or myeloprolifera-
tive disorders.
In the current case, the presence of a follicular lymph-
oma with a predominantly diffuse pattern demonstrated
in the EMH mass, in peripheral blood and in the bone
marrow, is quite remarkable. Our patient did not have
lymphadenopathies or other evident lesions suspicious
of FL by physical examination or imaging studies. This
situation is reminiscent of the recently described pri-
mary follicular lymphoma of the bone marrow in which
the tumor cells were observed in this location without
evidence of lymphadenopathies or organomegalies, al-
though three of the four patients also had circulating
tumor cells in peripheral blood as was observed in our
patient [28]. These four cases had a diffuse, nodular or
interstitial pattern of bone marrow infiltration, always
with involvement of the paratrabecular area. The re-
stricted expansion of lymphoma cells in the bone mar-
row in these cases suggests that the tumor cells may
have a particular tropism for the hematopoietic niche
[28]. The close association between the lymphoma cells
and the extramedullary hematopoiesis in our case may
suggest a similar phenomenon. Three of the previously
described patients were asymptomatic, while the fourth
one had history of bone pain without B symptoms. One
patient died three months after the diagnosis without
treatment response and the rest were alive at least one
year after, according to their clinical follow-up. The lack
of symptoms related to the lymphoma in our patient is
also similar to those patients with primary FL of the
bone marrow [28].
Conclusion
We present the case of a patient with hereditary sphero-
cytosis and secondary development of paraspinal extra-
medullary hematopoiesis and concurrent primary
follicular lymphoma. The diagnosis of this association is
rare and the presence of tumoral EMH may underesti-
mate the existence of an underlying lymphoma. The
close association between the tumor cells and extrame-
dullary hematopoiteic tissue suggests a relationship of
this tumor with the recently described primary FL of the
bone marrow.
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